Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 33 Fallopian Tube Neoplasms 21 Endometrial Neoplasms 17 Uterine Cervical Neoplasms 13 Colorectal Neoplasms 12 Neoplasm Metastasis 10 Pancreatic Neoplasms 9 Prostatic Neoplasms 8 Melanoma 8 Lung Neoplasms 8 Carcinoma, Renal Cell 7 Stomach Neoplasms 6 Carcinosarcoma 6 Carcinoma, Hepatocellular 6 Carcinoma, Transitional Cell 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Papillomavirus Infections 4 Esophageal Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Colonic Neoplasms 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma, Kaposi 2 Pelvic Neoplasms 2

Interventions

Hyperthermic Intraperitoneal Chemotherapy 28 Paclitaxel 24 Cisplatin 23 Oxaliplatin 18 Cytoreduction Surgical Procedures 17 Carboplatin 17 Fluorouracil 14 Bevacizumab 10 Mitomycin 9 Leucovorin 9 Doxorubicin 9 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4 Laparoscopy 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Specimen Handling × Gynecologic × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡